论文部分内容阅读
将血压正常的50例早期糖尿病肾病患者随机分为对照组和治疗组。对照组予以控制血糖、糖尿病教育等常规治疗;治疗组在常规治疗的基础上加用复方丹参滴丸15粒,3次/日,均治疗12周。完成治疗后观察患者尿微量白蛋白(MA)、肝功能、血尿常规等指标以评价其临床疗效和安全性。结果治疗组患者尿微量白蛋白较治疗前明显下降,具有统计学意义(P<0.01),与对照组比较具有统计学意义(P<0.05),而两组患者肝肾功能、血尿常规治疗后未见明显异常。结论复方丹参滴丸能有效改善早期糖尿病肾病患者的尿微量白蛋白水平,临床治疗效果明显,且药物使用安全性较高,在临床中可以推广应用。
50 cases of normal early diabetic nephropathy patients were randomly divided into control group and treatment group. The control group was given conventional therapy such as blood glucose and diabetes education. The treatment group was given 15 tablets of Danshen dripping pills on the basis of routine treatment for 3 times a day for 12 weeks. After completion of treatment, the patients’ urinary albumin (MA), liver function, hematuria and other indicators were observed to evaluate their clinical efficacy and safety. Results The urinary albumin in the treatment group was significantly lower than that before treatment (P <0.01), which was significantly higher than that in the control group (P <0.05). However, the liver and kidney function, No obvious abnormalities. Conclusion Compound Danshen Dripping Pill can effectively improve the level of urinary albumin in patients with early diabetic nephropathy. The clinical effect is obvious and the drug is safe to use. It can be widely used in clinic.